NYSE:APUS | Profit Breakdown | Apimeds Pharmaceuticals US, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$6.28M-$20.17M
2026-03-31-$12.19M-$35.06M
2025-12-31-$7.04M-$1.16M
2025-09-30-$1.84M-$1.78M
2025-06-30-$2.66M-$2.66M
2025-03-31-$364,368.00-$402,397.00
2024-12-31-$275,613.00-$311,633.00
2024-09-30-$299,999.00-$332,521.00
2024-06-30-$427,757.00-$449,363.00
2024-03-31-$271,726.00-$296,473.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$11.91M-$6M
2024-12-31-$1.28M-$1.39M
2023-12-31-$747,436.00-$777,694.00